These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29886548)

  • 21. Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
    Gerson JE; Sengupta U; Kayed R
    Methods Mol Biol; 2017; 1523():141-157. PubMed ID: 27975249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau and tauopathies.
    Lee G; Leugers CJ
    Prog Mol Biol Transl Sci; 2012; 107():263-93. PubMed ID: 22482453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
    Sydow A; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of Tau Oligomers After the Protein Extraction from Bacteria and Brain Cortices.
    Argyrousi EK; Staniszewski A; Nicholls RE; Arancio O
    Methods Mol Biol; 2018; 1779():85-97. PubMed ID: 29886529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling tauopathy: a range of complementary approaches.
    Hall GF; Yao J
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):224-39. PubMed ID: 15615641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of recombinant tau oligomers in vitro.
    Combs B; Tiernan CT; Hamel C; Kanaan NM
    Methods Cell Biol; 2017; 141():45-64. PubMed ID: 28882311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau Assembly into Filaments.
    Pérez M; Cuadros R; Medina M
    Methods Mol Biol; 2018; 1779():447-461. PubMed ID: 29886549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice.
    Zhu Y; Zhan G; Fenik P; Brandes M; Bell P; Francois N; Shulman K; Veasey S
    J Neurosci; 2018 Nov; 38(48):10255-10270. PubMed ID: 30322903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different tau species lead to heterogeneous tau pathology propagation and misfolding.
    Dujardin S; Bégard S; Caillierez R; Lachaud C; Carrier S; Lieger S; Gonzalez JA; Deramecourt V; Déglon N; Maurage CA; Frosch MP; Hyman BT; Colin M; Buée L
    Acta Neuropathol Commun; 2018 Nov; 6(1):132. PubMed ID: 30497516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.
    Theunis C; Adolfsson O; Crespo-Biel N; Piorkowska K; Pihlgren M; Hickman DT; Gafner V; Borghgraef P; Devijver H; Pfeifer A; Van Leuven F; Muhs A
    J Alzheimers Dis; 2017; 56(2):585-599. PubMed ID: 28035925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy.
    Barini E; Antico O; Zhao Y; Asta F; Tucci V; Catelani T; Marotta R; Xu H; Gasparini L
    Mol Neurodegener; 2016 Feb; 11():16. PubMed ID: 26858121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.
    Nilson AN; English KC; Gerson JE; Barton Whittle T; Nicolas Crain C; Xue J; Sengupta U; Castillo-Carranza DL; Zhang W; Gupta P; Kayed R
    J Alzheimers Dis; 2017; 55(3):1083-1099. PubMed ID: 27716675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Travels with tau prions.
    Diamond MI
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):83-88. PubMed ID: 37950616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of assembly of tau(273-284) and its ΔK280 mutant: an experimental and computational study.
    Larini L; Gessel MM; LaPointe NE; Do TD; Bowers MT; Feinstein SC; Shea JE
    Phys Chem Chem Phys; 2013 Jun; 15(23):8916-28. PubMed ID: 23515417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model.
    Cook C; Kang SS; Carlomagno Y; Lin WL; Yue M; Kurti A; Shinohara M; Jansen-West K; Perkerson E; Castanedes-Casey M; Rousseau L; Phillips V; Bu G; Dickson DW; Petrucelli L; Fryer JD
    Hum Mol Genet; 2015 Nov; 24(21):6198-212. PubMed ID: 26276810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of in vivo turnover of tau in a mouse model of tauopathy.
    Yamada K; Patel TK; Hochgräfe K; Mahan TE; Jiang H; Stewart FR; Mandelkow EM; Holtzman DM
    Mol Neurodegener; 2015 Oct; 10():55. PubMed ID: 26502977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
    Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seed-competent tau monomer initiates pathology in a tauopathy mouse model.
    Mirbaha H; Chen D; Mullapudi V; Terpack SJ; White CL; Joachimiak LA; Diamond MI
    J Biol Chem; 2022 Aug; 298(8):102163. PubMed ID: 35750209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.